Long-Term Outcomes of On- Versus Off-Pump Coronary Artery Bypass Grafting

Neil A Smart1, Gudrun Dieberg1, Nicola King2

  • 1School of Science and Technology, University of New England, Armidale, Australia.

Insights

On-pump coronary artery bypass grafting (CABG) shows statistically superior long-term survival compared to off-pump CABG. However, the clinical significance of this survival benefit requires further investigation.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Meta-Analysis and Systematic Review

Background:

  • Assessing long-term clinical outcomes of on-pump versus off-pump coronary artery bypass grafting (CABG) is crucial.
  • Existing research predominantly focuses on short-term results, neglecting crucial 5-year outcomes from major trials.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis evaluating long-term clinical outcomes after on-pump versus off-pump CABG.
  • To specifically analyze 5-year outcomes, including mortality, myocardial infarction, angina, revascularization, and stroke incidence.

Main Methods:

  • Systematic literature searches were performed across multiple databases.
  • Search terms included 'cardiopulmonary bypass,' 'off-pump,' and 'long term OR 5-year outcomes.'
  • A meta-analysis compared key clinical endpoints between on-pump and off-pump CABG groups.

Main Results:

  • Analysis of six studies involving 8,145 participants revealed a statistically significant higher mortality in the off-pump group (13.9%) compared to the on-pump group (12.3%) (OR: 1.16; p=0.03).
  • No significant differences were observed in the incidence of myocardial infarction (OR: 1.06), angina (OR: 1.09), need for revascularization (OR: 1.15), or stroke (OR: 0.78) between the two groups.
  • Confidence intervals for non-mortality outcomes indicated no statistically significant differences.

Conclusions:

  • On-pump CABG demonstrated a statistically significant advantage in long-term survival.
  • The clinical relevance of this survival difference warrants further consideration and investigation.
  • Long-term outcomes beyond mortality did not differ significantly between on-pump and off-pump CABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.9K